ARCHIVES

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 38 | October 6, 1989

Download PDF Visit The Full Archive

Related Articles

NCI Largely Unaffected By NIH Translational Research Center

February 11, 2011

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

August 31, 2012

NIGMS Awards First Grants For Gene Mapping

August 19, 1988

“Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions

September 14, 2012

Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds

April 27, 2007

McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.

June 2, 2000